Menu
Recruiting NCT07073508

The Validity of the Evaluation of Renal Artery Duplex in Critically Ill Acute Kidney Injury Patients

Observational Validity Renal Artery Duplex Critically Ill Acute Kidney Injury

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Renal Artery Duplex.
Who it may be relevant to
Registry conditions: Validity, Renal Artery Duplex, Critically Ill Acute Kidney Injury. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

This study aims to assess the clinical relevance of renal artery duplex ultrasound in critically ill patients with acute kidney injury (AKI) in terms of the renal resistive index (RRI).

Detailed description

Diagnosis of acute kidney injury (AKI) is based on rising creatinine as late phenomenon. Intrarenal vasoconstriction occurs earlier, so measuring flow resistance in the renal circulation, renal resistive index (RRI), could become part of vital organ function assessment using Doppler ultrasound.

Interventions

  • Other Renal Artery Duplex
    Renal artery duplex will be performed to all patients in terms of renal resistivity index (RRI).

Primary outcome measures

  • Renal resistivity index (RRI) [Time frame: 1 week post-procedure]

Eligibility criteria

Inclusion criteria

  • Patients age >18 years.
  • Both sexes.
  • Patients within 24 hours after intensive care unit (ICU) admission.

Exclusion criteria

  • Patients presented with poor abdominal echogenicity.
  • Chronic kidney disease, especially with estimated creatinine clearance less than 30 ml/min/1.73m.
  • Patients with dialysis dependency.
  • Patients with renal transplantation.
  • Patients with known renal artery stenosis.
  • If there is a pregnancy.
  • Patients with any congenital kidney diseases as mono-kidney, anatomic kidney abnormalities.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

Egypt · 1 center
  • Ain Shams University — Cairo

Identifiers

NCT: NCT07073508 · FMASU MD51/2024

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗